Maurie Markman, MD
The ongoing revolution in our understanding of the fundamental biology of cancer has resulted in truly impressive advances in treatment and strategies to optimize clinical outcomes. Further, repeat tumor sampling or obtaining liquid tumor biopsies over the natural history of an individual’s cancer may provide critically relevant data about mutational events leading to drug resistance. In turn, this information will increasingly permit far more efficacious decisions regarding second and later lines of antineoplastic drug therapy.
... to read the full story